AAPS Names 2001 Fellows

Thirteen Honored for Professional Excellence in Pharmaceutical Sciences

ARLINGTON, Va. - The American Association of Pharmaceutical Scientists (AAPS) unveiled its annual list of fellows. An AAPS Fellow earns his or her title by contributing scholarly research, such as original articles, patents and presentations, in the pharmaceutical sciences. The fellows will be honored at the 2001 AAPS Annual Meeting opening session on Oct. 21, 2001 in Denver.

This year, the following thirteen individuals join the prestigious list of AAPS Fellows:

Per Artursson, Ph.D. , professor of dosage form design, Uppsala University, Sweden. Artursson's research is focused on intestinal drug absorption and delivery. The goal of his work is to understand drug absorption at the molecular and cellular level in order to deliver drugs more effectively via the oral route.

Robert A. Blouin, Pharm.D. , professor of pharmaceutical sciences, University of Kentucky. Blouin's research focuses on the effect of various disease states and altered physiologic states on the expression and regulation of drug metabolizing enzymes.

Marcus E. Brewster, III, Ph.D. , head, Department of Drug Delivery Research, Janssen Research Foundation, Beerse, Belgium. Brewster's main research interests include the use of chemically modified cylcodextrin derivatives for pharmaceutical application, brain-targeted drug delivery through the use of chemical delivery systems and the application of molecular orbital and other computational approaches in addressing items of chemical and biological concern.

Carla M. Caramella, Pharm.D. , professor of pharmaceutical technology and biopharmacy, Department of Pharmaceutical Chemistry, University of Pavia, Italy. Caramella's current research interests are in the design and evaluation of delivery systems, including mucoadhesive gels for buccal and vaginal antiviral treatment, prolonged release oral dosage forms based on anionic polymer-basic drug interaction products, and films for ocular therapy.

Mei-Ling Chen, Ph.D. , associate director, Office of Pharmaceutical Science in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA). Chen has made outstanding contributions to the FDA's policy and guidance development in the areas of biopharmaceutics and clinical pharmacology. Her achievements have had tremendous impact on the drug development as well as regulatory approval of new drug products and their generic equivalents.

Jeffrey L. Cleland, Ph.D. , senior scientist, Pharmaceutical Research & Development Department, Genentech. He has co-led the development team for Nutropin Depot™ with Alkermes and the manufacturing team for Herceptin®. He currently leads the manufacturing team for immunotoxins.

Chong-Kook Kim, Ph.D. , professor of pharmacy and director, National Research Lab for Drug and Gene Delivery, College of Pharmacy, Seoul National University, Korea. Through his research, Kim has made major contributions in the development of delivery systems for drugs, genes and other bioactive substances.

Jeffrey Kotzan, Ph.D. , professor of clinical and administrative sciences, College of Pharmacy, University of Georgia. Kotzan's research accomplishments span three decades tied together by his passion for modeling, computers, and statistical analyses.

Lawrence J. Lesko, Ph.D. , director, Office of Clinical Pharmacology and Biopharmaceutics (OCPB), FDA. Lesko has worked to develop and establish good review practices and sound scientific standards for the regulatory assessment of clinical pharmacology and biopharmaceutical studies that are submitted in the FDA's investigational new drug applications and new drug applications.

Susan M. Lunte, Ph.D. , professor of pharmaceutical chemistry, University of Kansas. Lunte's major research contributions are in the field of bioanalytical chemistry. She is a leader in the application of capillary electrophoresis to pharmaceutical analysis. More recently, she has been involved in the development of microchip analytical systems for clinical analysis using electrochemical detection.

Charles Russell Middaugh, Ph.D. , Aya and Takeru Higuchi Distinguished Professor of Pharmaceutical Chemistry, University of Kansas. Middaugh is especially well known for his work in the area of protein and polynucleotide formulation and characterization with especially notable efforts in the areas of solubility and stabilization.

Gary M. Pollack, Ph.D. , professor and chair, Division of Drug Delivery and Disposition, School of Pharmacy, The University of North Carolina. Pollack's research is centered on the disposition and action of drugs and toxicants in the central nervous system.

Yongyut Rojanasakul, Ph.D. , professor of pharmaceutical sciences, West Virginia University. Rojanasakul has conducted pioneering research in pharmaceutical biotechnology and drug delivery. He has contributed significantly to the fields of gene and antisense therapy, drug transport, and molecular drug targeting.

About AAPS
AAPS is a professional, scientific society of more than 11,000 members employed in academia, industry, government and other research institutes worldwide. For more information about AAPS, visit AAPS Pharmaceutica at www.aapspharmaceutica.com.

EDITOR'S NOTE: For more information or for photos of the new AAPS Fellows, contact Debbie Werfel at 703-248-4743 or James Greif at 703-248-4744.

*     *     *